Gilead Sciences Inc (GILD)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ
Market Cap: $208.48B
Last updated: Nov 17, 2026 at 11:06 AM ET
Gilead Sciences Inc (GILD) Competitors
The companies most similar to Gilead Sciences are GSK (GSK), Amgen (AMGN) and Bristol-Myers Squibb Company (BMY). By market cap, Gilead Sciences ranks 7th of the 13 companies on this page; Eli Lilly and Company (LLY) is the largest at $1.29T. The median P/E of the 10 companies with a P/E is 20.7x.
Peer Comparison
GILD's ROIC of -3.9% is below the peer median of 13.9%, and its revenue growth of 6.8% is in line with the median. Its dividend yield is below the peer median of 2.67%.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Gilead Sciences (GILD) | $208.48B | N/A | 6.7x | -12.5% | -3.9% | 6.8% | 1.96% |
| GSK plc (GSK) | $101.13B | 10.5x | 2.3x | 13.0% | N/A | 4.0% | 3.58% |
| Amgen Inc (AMGN) | $251.89B | 19.9x | 6.4x | 24.1% | 17.0% | 8.5% | 2.18% |
| Bristol-Myers Squibb Company (BMY) | $129.66B | 10.1x | 2.6x | 18.5% | 13.9% | 6.9% | 4.00% |
| Novo Nordisk A/S (NVO) | $183.52B | N/A | 3.6x | 33.9% | 34.1% | 5.6% | 4.32% |
| Pfizer Inc (PFE) | $164.67B | 9.5x | 2.6x | 6.3% | 2.7% | -0.4% | 5.96% |
| Sanofi ADR (SNY) | $116.15B | N/A | 2.0x | 8.2% | 7.6% | 15.7% | 5.01% |
| AstraZeneca PLC (AZN) | $286.07B | 22.5x | 4.6x | 17.7% | 14.9% | 6.7% | 1.16% |
| AbbVie Inc (ABBV) | $521.50B | 23.0x | 7.9x | 15.7% | 16.4% | 10.3% | 2.35% |
| Novartis AG ADR (NVS) | $303.12B | 18.7x | 5.4x | 17.5% | 13.5% | 4.7% | 2.98% |
| Merck & Company Inc (MRK) | $364.26B | 46.3x | 5.3x | 3.6% | 3.1% | 4.7% | 2.35% |
| Biogen Inc (BIIB) | $37.46B | 21.4x | 3.6x | 3.4% | 1.3% | 10.6% | 0.00% |
| Eli Lilly and Company (LLY) | $1.29T | 44.9x | 14.8x | 31.9% | 30.7% | 38.6% | 0.48% |
| Peer median | $217.70B | 20.7x | 4.1x | 16.6% | 13.9% | 6.8% | 2.67% |
Similar Companies
These are the 12 companies most similar to Gilead Sciences, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - General.
| Company | About | Peers |
|---|---|---|
| GSK plc (GSK) | GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines... | GSK competitors |
| Amgen Inc (AMGN) | Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. | AMGN competitors |
| Bristol-Myers Squibb Company (BMY) | Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. | BMY competitors |
| Novo Nordisk A/S (NVO) | Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. | NVO competitors |
| Pfizer Inc (PFE) | Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. | PFE competitors |
| Sanofi ADR (SNY) | Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe... | SNY competitors |
| AstraZeneca PLC (AZN) | AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory... | AZN competitors |
| AbbVie Inc (ABBV) | AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories. | ABBV competitors |
| Novartis AG ADR (NVS) | Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland. | NVS competitors |
| Merck & Company Inc (MRK) | Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. | MRK competitors |
| Biogen Inc (BIIB) | Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development... | BIIB competitors |
| Eli Lilly and Company (LLY) | Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. | LLY competitors |
Frequently Asked Questions About GILD
Who are Gilead Sciences' main competitors?
The companies most similar to Gilead Sciences include GSK (GSK), Amgen (AMGN), Bristol-Myers Squibb Company (BMY), Novo Nordisk A/S (NVO) and Pfizer (PFE), listed from the closest match.
Who is Gilead Sciences' biggest competitor?
Eli Lilly and Company (LLY) is the largest of the similar companies at $1.29T; GSK (GSK) is the closest match by business profile, size, sector and industry.
How does GILD stock compare with its competitors?
GILD's P/S is 6.7x against a peer median of 4.1x; its net margin is -12.5% against a peer median of 16.6%.
Which of Gilead Sciences' competitors pays a higher dividend?
Gilead Sciences has a forward dividend yield of 1.96%. Pfizer (PFE), Sanofi ADR (SNY), Novo Nordisk A/S (NVO), Bristol-Myers Squibb Company (BMY), GSK (GSK), Novartis AG ADR (NVS), Merck & Company (MRK), AbbVie (ABBV) and Amgen (AMGN) have higher forward dividend yields; Pfizer (PFE) has the highest at 5.96%.
Is Gilead Sciences bigger than its competitors?
No. Gilead Sciences is 7th by market cap among the 13 companies on this page; the largest is Eli Lilly and Company (LLY) at $1.29T.
GILD pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts